Your browser doesn't support javascript.
loading
Tobacco use in first-episode psychosis, a multinational EU-GEI study.
Sánchez-Gutiérrez, T; Rodríguez-Toscano, E; Roldán, L; Ferraro, L; Parellada, M; Calvo, A; López, G; Rapado-Castro, M; La Barbera, D; La Cascia, C; Tripoli, G; Di Forti, M; Murray, R M; Quattrone, D; Morgan, C; van Os, J; García-Portilla, P; Al-Halabí, S; Bobes, J; de Haan, L; Bernardo, M; Santos, J L; Sanjuán, J; Arrojo, M; Ferchiou, A; Szoke, A; Rutten, B P; Stilo, S; D'Andrea, G; Tarricone, I; Díaz-Caneja, C M; Arango, C.
Afiliação
  • Sánchez-Gutiérrez T; Faculty of Health Science, Universidad Internacional de la Rioja (UNIR), Logroño, Spain.
  • Rodríguez-Toscano E; Grupo de investigación en Psiquiatría, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
  • Roldán L; Department of Experimental Psychology, Cognitive Processes and Speech Therapy at the Complutense University of Madrid, Madrid, Spain.
  • Ferraro L; Faculty of Psychology, Universidad Complutense de Madrid, Madrid, Spain.
  • Parellada M; Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
  • Calvo A; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.
  • López G; Faculty of Psychology, Universidad Complutense de Madrid, Madrid, Spain.
  • Rapado-Castro M; Faculty of Health Science, Universidad Internacional de la Rioja (UNIR), Logroño, Spain.
  • La Barbera D; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.
  • La Cascia C; Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, 161 Barry Street, Carlton South, Victoria 3053, Australia.
  • Tripoli G; Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
  • Di Forti M; Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
  • Murray RM; Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo, Palermo, Italy.
  • Quattrone D; Department of Social Genetics and Developmental Psychiatry, Institute of Psychiatry Psychology & Neuroscience, King's College London, London, UK.
  • Morgan C; South London and Maudsley NHS Foundation Mental Health Trust, London, UK.
  • van Os J; Department of Social Genetics and Developmental Psychiatry, Institute of Psychiatry Psychology & Neuroscience, King's College London, London, UK.
  • García-Portilla P; Department of Social Genetics and Developmental Psychiatry, Institute of Psychiatry Psychology & Neuroscience, King's College London, London, UK.
  • Al-Halabí S; ESRC Centre for Society and Mental Health, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Bobes J; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • de Haan L; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
  • Bernardo M; Department Psychiatry, Brain Centre Rudolf Magnus, Utrecht University Medical Centre, Utrecht, The Netherlands.
  • Santos JL; Department of Medicine-Psychiatry, Universidad de Oviedo, ISPA, INEUROPA, CIBERSAM, Oviedo, Spain.
  • Sanjuán J; Department of Psychology, University of Oviedo, Oviedo, Spain.
  • Arrojo M; Department of Medicine-Psychiatry, Universidad de Oviedo, ISPA, INEUROPA, CIBERSAM, Oviedo, Spain.
  • Ferchiou A; Early Psychosis Department, Amsterdam UMC, University of Amsterdam, Academic Psychiatric Centre, Arkin, Amsterdam, The Netherlands.
  • Szoke A; Barcelona Clinic Schizophrenia Unit, Hospital Clinic, Departament de Medicina, Institut de Neurociències (UBNeuro), Universitat de Barcelona (UB), Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), CIBERSAM, ISCIII, Barcelona, Spain.
  • Rutten BP; Department of Psychiatry, Servicio de Psiquiatría Hospital 'Virgen de la Luz', Cuenca, Spain.
  • Stilo S; Department of Psychiatry, Hospital Clínico Universitario de Valencia, INCLIVA, CIBERSAM, School of Medicine, Universidad de Valencia, Valencia, Spain.
  • D'Andrea G; Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Tarricone I; Fondation FondaMental, Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.
  • Díaz-Caneja CM; Fondation FondaMental, Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.
  • Arango C; AP-HP, Hopitaux Universitaires 'H. Mondor', DMU IMPACT, F-94010 Creteil, France.
Psychol Med ; 53(15): 7265-7276, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37185055

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Cannabis / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Psychol Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Cannabis / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Psychol Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha